Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the ...
In connection with the proposed Sale, Pixelworks has filed a proxy statement on Schedule 14A with the SEC. INVESTORS AND SHAREHOLDERS ARE URGED TO READ CAREFULLY THE DEFINITIVE PROXY STATEMENT AND ANY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback